Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling

OBJECTIVE: Macrophage interleukin (IL)-10 signalling plays a critical role in the maintenance of a regulatory phenotype that prevents the development of IBD. We have previously found that anti-tumour necrosis factor (TNF) monoclonal antibodies act through Fcγ-receptor (FcγR) signalling to promote re...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Gut
Päätekijät: Koelink, Pim J, Bloemendaal, Felicia M, Li, Bofeng, Westera, Liset, Vogels, Esther W M, van Roest, Manon, Gloudemans, Anouk K, van 't Wout, Angelique B, Korf, Hannelie, Vermeire, Séverine, te Velde, Anje A, Ponsioen, Cyriel Y, D'Haens, Geert RAM, Verbeek, J Sjef, Geiger, Terrence L, Wildenberg, Manon E, van den Brink, Gijs R
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2020
Aiheet:
Inflammatory Bowel Disease
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7282553/
https://ncbi.nlm.nih.gov/pubmed/31506328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2019-318264
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia